Mortsel, Belgium

Agfa-Gavaert N.v.


USPTO Granted Patents = 7

% Expired Patents = 14.3

Forward Citations = 26

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Luc J Vanmaele (2 out of 101 patents)

silverMedal Michel Werts (1 out of 5 patents)

bronzeMedal Hubert Vandenabeele (1 out of 22 patents)

4.  Wilhelm Julicher (1 out of 1 patent)

5.  Gerald Gaumitz (1 out of 1 patent)

6.  Gert Huppertz (1 out of 1 patent)

7.  Herman J Uytterhoeven (1 out of 64 patents)

8.  Luc H Leenders (1 out of 117 patents)

9.  Eddie R Daems (1 out of 51 patents)

10.  Serge M Tavernier (1 out of 64 patents)

11.  Rene M De Keyzer (1 out of 25 patents)

12.  Jos A Vaes (1 out of 26 patents)

13.  Jean-Marie O Dewanckele (1 out of 41 patents)

14.  Wilhelmus Janssens (1 out of 75 patents)

15.  Ludo L Van Rompuy (1 out of 5 patents)


7 patents:

Company Overview
Agfa-Gevaert N.V. is a global imaging company headquartered in Belgium, specializing in imaging technology and healthcare IT services. The company offers a wide range of products and solutions, including digital imaging systems, printing technologies, and healthcare IT solutions. With a history dating back to 1867, Agfa-Gevaert has established itself as a leader in the imaging industry, serving customers in over 100 countries worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#10 in Mortsel

#338 in Belgium

Mortsel, BE
Mortsel, Belgium
Forward Citations = 26

17 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Agfa-Gavaert N.v.. Retrieved from https://idiyas.com/company/agfa-gavaert-n-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…